サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1361560

医療用大麻市場- 世界の産業規模、シェア、動向、機会、予測、2018-2028年

Medical Cannabis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented By Product Type, By Active Ingredient, By Distribution Channel, By Application, By End User Industry, By Region and Competition
出版日: | 発行: TechSci Research | ページ情報: 英文 180 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

医療用大麻市場- 世界の産業規模、シェア、動向、機会、予測、2018-2028年
出版日: 2023年10月03日
発行: TechSci Research
ページ情報: 英文 180 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 目次
概要

世界の医療用大麻市場はCAGR 14.62%を記録し、2028年までに475億8,000万米ドルに達すると予想されます。

これは、政府からの資金提供の増加、研究開発活動（R&D）の増加、世界中で受け入れが進んでいることに起因しています。医療用大麻市場は急速に成長している産業であり、世界中の多くの国で受け入れられ、法的な認知度が高まっています。

医療用大麻とは、慢性疼痛、吐き気、発作、不安などを含む様々な病状を治療するために、大麻植物またはその抽出物を使用することを指します。医療用大麻市場には、乾燥大麻の花、オイル、カプセル、チンキ剤、エディブルなど、幅広い製品が含まれます。これらの製品は、患者のニーズや好みに応じて、喫煙、気化、摂取などさまざまな方法で投与することができます。医療用大麻市場の成長を促進する主な要因の1つは、合法的な医療治療の選択肢として大麻が一般に受け入れられつつあることです。大麻の医学的特性に関する研究が進み、大麻を使用して病状を管理することで良好な結果が得られたと報告する患者が増えるにつれて、医療用大麻製品に対する需要が高まっています。オーストラリアでは2016年に医療用大麻が合法化され、Therapeutic Goods Administrationの調査によると、医療用大麻の処方件数は2017年の1,000件から2021年には10万件以上に増加しています。

企業プロファイル：世界の医療用大麻市場に参入している主要企業の詳細分析

利用可能なカスタマイズ：

TechSci Research社は、与えられた市場データをもとに、企業固有のニーズに応じたカスタマイズを提供しています。レポートでは以下のカスタマイズが可能です：

企業情報

  • 追加市場参入企業（最大5社）の詳細分析とプロファイリング

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 臨床試験分析

第6章 世界の医療用大麻市場の展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 製品タイプ別（蕾/マリファナフラワー、大麻エキス）
    • 有効成分別（テトラヒドロカンナビノール（THC）、カンナビジオール（CBD）、その他の活動）
    • 流通チャネル別（B2B、B2C）
    • 用途別（慢性疼痛、精神障害、がん、てんかん、その他）
    • エンドユーザー産業別（製薬・バイオテクノロジー企業、学術・調査機関、その他）
    • 地域別
    • 企業別（2022年）
  • 製品マップ
    • 製品タイプ別
    • 有効成分別
    • 流通チャネル別
    • 用途別
    • エンドユーザー別
    • 地域別

第7章 北米医療用大麻市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • 製品タイプ別
    • 有効成分別,カンナビジオール,その他の活動
    • 流通チャネル別
    • 用途別
    • エンドユーザー産業別
    • 国別
  • 北米国別分析
    • 米国
    • カナダ
    • メキシコ

第8章 欧州医療用大麻市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • 製品タイプ別
    • 有効成分別,カンナビジオール,その他の活動
    • 流通チャネル別
    • 用途別
    • エンドユーザー産業別
    • 国別
  • 欧州国別分析
    • ドイツ
    • マルタ
    • 英国
    • フランス
    • デンマーク
    • イタリア
    • スペイン

第9章 アジア太平洋医療用大麻市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • 製品タイプ別
    • 有効成分別,カンナビジオール,その他の活動
    • 流通チャネル別
    • 用途別
    • エンドユーザー産業別
    • 国別
  • アジア太平洋地域国別分析
    • オーストラリア
    • 中国
    • タイ
    • 韓国
    • インド

第10章 南米医療用大麻市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • 製品タイプ別
    • 有効成分別,カンナビジオール,その他の活動
    • 流通チャネル別
    • 用途別
    • エンドユーザー産業別
    • 国別
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第11章 中東・アフリカ医療用大麻市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • 製品タイプ別
    • 有効成分別,カンナビジオール,その他の活動
    • 流通チャネル別
    • 用途別
    • エンドユーザー産業別
    • 国別
  • MEA：国別分析
    • レバノン
    • 南アフリカ
    • イスラエル

第12章 市場力学

  • 促進要因
    • 慢性疾患の高い蔓延
    • 医療用大麻の合法化
  • 課題
    • コストが高く、常に入手可能とは限らない
    • 消費者に受け入れられにくい

第13章 市場動向と発展

  • 新製品の開発
  • 医薬品・製薬業界による医療用大麻の使用の増加

第14章 世界の医療用大麻市場SWOT分析

第15章 ポーターのファイブフォース分析

  • 業界内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第16章 競合情勢

  • Business Overview
  • Product Offerings
  • Recent Developments
  • Financials（As Reported）
  • Key Personnel
  • SWOT Analysis
      • Canopy Growth Corporation
      • Aphria, Inc.
      • Maricann Group, Inc
      • Tikun Olam-Cannabit Pharmaceuticals Ltd
      • MedReleaf. Corp
      • GW Pharmaceuticals plc.
      • Cannabis Sativa, Inc.
      • Medical Marijuana, Inc
      • Aurora Marijuana Inc.
      • Cronos Group Inc.

第17章 戦略的提言

目次
Product Code: 15430

Global medical cannabis market is expected to register a CAGR of 14.62% and reach USD 47.58 billion by 2028. This is attributed to the growing government fundings, increase in research and development activities (R&D), and growing acceptance across the world. The medical cannabis market is a rapidly growing industry that is gaining acceptance and legal recognition in many countries around the world.

Medical cannabis refers to the use of the cannabis plant or its extracts to treat a range of medical conditions, including chronic pain, nausea, seizures, and anxiety, among others. The market for medical cannabis includes a wide range of products, including dried cannabis flower, oils, capsules, tinctures, and edibles. These products can be administered in different ways, such as smoking, vaporizing, or ingestion, depending on the patient's needs and preferences. One of the main factors driving the growth of the medical cannabis market is increasing public acceptance of cannabis as a legitimate medical treatment option. As more research is conducted into the medical properties of cannabis and more patients report positive outcomes from using cannabis to manage their conditions, demand for medical cannabis products is growing. In Australia, medical cannabis was legalized in 2016, and the number of medical cannabis prescriptions has increased from 1,000 in 2017 to over 100,000 in 2021, according to the surveys conducted by Therapeutic Goods Administration.

The medical cannabis market is benefiting from advancements in cannabis cultivation and production techniques, which are leading to higher-quality products and greater consistency in dosing and potency. The legalization of medical cannabis has made it easier for patients to access this treatment option, especially in places where it was previously illegal. A study published in JAMA Internal Medicine found that states with medical cannabis laws had a 25% lower opioid overdose mortality rate compared to states without medical cannabis laws.

Hence, the medical cannabis market is expected to continue to grow as more patients and healthcare professionals recognize the potential benefits of cannabis as a medical treatment option and as more countries legalize medical cannabis use. This advancements and legalization of medical cannabis in different countries is likely to boost the medical cannabis market in the forecast period.

Legalization of Medical Cannabis to drive the Medical Cannabis Market Growth

The medical cannabis market has been rapidly growing in recent years due to various factors such as changing public attitudes towards the medical cannabis, patient testimonials, and opioid crisis. The legalization of medical cannabis in many countries and states has led to increased availability and accessibility of cannabis for medical use. This has helped to create a legal framework for the production, distribution, and consumption of medical cannabis products, making it easier for patients to access them. Also, there is growing acceptance and awareness about the potential benefits of medical cannabis in treating a wide range of medical conditions such as chronic pain, anxiety, and epilepsy. This has led to increased demand for medical cannabis products, and more people are willing to try them as a potential alternative to traditional medications. As more research is conducted on the potential health benefits of medical cannabis, more evidence is emerging to support medical cannabis use in the treatment of various medical conditions. This has helped to increase the credibility of medical cannabis as a legitimate treatment option, which in turn has encouraged more patients to consider using it. Therefore, the growing occurrences of chronic diseases across the globe is influencing the growth of the global medical cannabis market in the coming years

Legalization increases the number of patients who can access medical cannabis products. When medical cannabis is illegal, patients may be forced to obtain it from the black market, which can be risky and unsafe. Legalization ensures that patients have access to legal and regulated products, which can help to improve the quality of their healthcare. In addition to improving access and safety, legalization creates economic opportunities in the medical cannabis market. Legalization can create jobs, generate tax revenue, and encourage investment in research and development. This can help to drive innovation in the medical cannabis industry, leading to the development of new and more effective products. Countries that legalize medical cannabis can benefit from the economic and public health potential, and manage the legal and social implications. In 2018, the World Health Organization Expert Committee on Drug Dependence, conducted a review of cannabis and its derivatives, including cannabidiol (CBD) and tetrahydrocannabinol (THC), and recommended that cannabis and certain cannabis-related substances should be rescheduled under international drug control conventions to facilitate research into their potential therapeutic uses. Also, WHO stated that CBD has been shown to be effective in treating some forms of epilepsy and tetrahydrocannabinol (THC) may have therapeutic benefits for certain medical conditions such as chronic pain, nausea, and vomiting.

Growing Acceptance and Awareness About the Potential Benefits Drive the Market

Growing acceptance and awareness about the potential benefits of medical cannabis is leading to an increase in demand for medical cannabis in the market. Cannabis contains compounds called cannabinoids, which have been found to have various therapeutic properties for example, cannabinoids can help alleviate symptoms of chronic pain, nausea and vomiting, anxiety, and sleep disorders. In response, more countries and states are legalizing medical cannabis, which further drives the demand. Additionally, advancements in technology have made it easier to extract and produce cannabis-based products, making them more accessible to patients who need them. Therefore, the growing acceptance and awareness of medical cannabis are driving the demand for medical cannabis in the market.

Also, more countries and states legalize medical cannabis, more patients have access to medical cannabis. This has led to a significant increase in demand as patients seek alternative therapies to traditional medicines. Cannabis-based products are being marketed more effectively, with companies emphasizing their therapeutic properties and safety. This has led to increased consumer awareness and demand. The perception of cannabis has shifted in recent years, with more people accepting cannabis potential medical benefits. This has led to greater demand from patients who may have previously been reluctant to try medical cannabis. Therefore, the growing acceptance of people towards the use of medical cannabis is likely to fuel the medical cannabis market in the forecast period.

Medical cannabis has been found to have several potential benefits in treating various medical conditions such as Medical cannabis has shown to be effective in reducing chronic pain, including neuropathic pain, back pain, and arthritis. Cannabis-based products can be effective in reducing nausea and vomiting caused by chemotherapy, HIV/AIDS medications, and other medical treatments. Cannabinoids found in medical cannabis have been shown to reduce symptoms of anxiety and depression. As Per The Data Quoted By The National Conference Of State Legislatures, As of April 24, 2023, the District of Columbia, three territories, and 38 states permit the use of cannabis products for medical purposes.

Hence, the growing acceptance and awareness of medical cannabis has created a significant increase in demand for medical cannabis in the market, with patients seeking alternative therapies for a range of medical conditions.

Favorable Government initiatives and Policies Drive the Medical Cannabis Market Growth

Favorable government initiatives and policies drives the growth of the medical cannabis market as more and more countries and states legalize medical cannabis, there is a growing demand for products that contain cannabis and its derivatives. Government initiatives that support research and development of medical cannabis, provide funding for medical cannabis businesses, and streamline the regulatory process that contribute to the growth of the medical cannabis market.

In addition, government policies that allow for easier access to medical cannabis for patients and healthcare professionals, such as removing barriers to prescribing and dispensing, can help to drive the growth. This can lead to increased adoption of medical cannabis as a treatment option, which in turn can drive demand for related products and services. However, different countries and states have different policies and regulations regarding medical cannabis. Some may have strict requirements for licensing, testing, and quality control, while others may have more relaxed regulations. Therefore, the growth of the medical cannabis market can vary depending on the specific regulatory environment in a given region. According to the data quoted by Savills plc, the majority of the world's legal medicinal cannabis is produced in the UK. The UK output of cannabis-derived pharmaceuticals surged by nearly 500% between 2015 and 2017, reaching 235 tonnes, making it the largest global producer by a significant margin.

Market Segmentation

Global medical cannabis market is segmented based on product type, active ingredient, distribution channel, application, end user, and region. Based on product type, the medical cannabis market is segmented into buds/marijuana flower and cannabis extracts. Based on active ingredient, the medical cannabis market is segmented into Tetrahydrocannabinol (THC), Cannabidiol (CBD), and others. Based on distribution channel, the medical cannabis market is segmented into B2B and B2C. Based on application, the medical cannabis market is divided into chronic pain, mental disorders, cancer, epilepsy, and others. Based on end user, the medical cannabis market is segmented into pharmaceutical & biotechnology companies, academic & research institutions, and others. Based on region, the medical cannabis market is divided into North America, Europe, Asia Pacific, South America, Middle East & Africa.

Company Profiles

Canopy Growth Corporation., Aphria, Inc., Maricann Group, Inc., Tikun Olam - Cannabit Pharmaceuticals Ltd., MedReleaf. Corp., GW Pharmaceuticals plc., Cannabis Sativa, Inc., Medical Marijuana, Inc., Aurora Marijuana Inc., and Cronos Group Inc are some of the key players of global medical Cannabis market.

Report Scope:

In this report, global Medical Cannabis market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

  • Medical Cannabis Market, By Product Type:

Buds/Marijuana Flower

Cannabis Extracts

  • Medical Cannabis Market, By Active Ingredient:

Tetrahydrocannabinol (THC)

Cannabidiol (CBD)

Others

  • Medical Cannabis Market, By Distribution Channel:

B2B

B2C

  • Medical Cannabis Market, By Application:

Chronic Pain

Mental Disorders

Cancer

Epilepsy

Others

  • Medical Cannabis Market, By End User:

Pharmaceutical & Biotechnology Companies

Academic & Research Institutions

Others

  • Medical Cannabis Market, By Region:

North America

  • United States
  • Mexico
  • Canada

Europe

  • Germany
  • Malta
  • United Kingdom
  • France
  • Denmark
  • Italy
  • Spain

Asia-Pacific

  • Australia
  • China
  • Thailand
  • South Korea
  • India

South America

  • Brazil
  • Argentina
  • Colombia

Middle East & Africa

  • Lebanon
  • South Africa
  • Israel

Competitive landscape

Company Profiles: Detailed analysis of the major companies present in the global Medical Cannabis market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Clinical Trial Analysis

  • 5.1. Ongoing Clinical Trials
  • 5.2. Completed Clinical Trials
  • 5.3. Terminated Clinical Trials
  • 5.4. Breakdown of Pipeline, By Development Phase
  • 5.5. Breakdown of Pipeline, By Status
  • 5.6. Breakdown of Pipeline, By Study Type
  • 5.7. Breakdown of Pipeline, By Region
  • 5.8. Clinical Trials Heat Map

6. Global Medical Cannabis Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type (Buds/Marijuana Flower, Cannabis Extracts)
    • 6.2.2. By Active Ingredient (Tetrahydrocannabinol (THC), Cannabidiol (CBD), Others)
    • 6.2.3. By Distribution Channel (B2B, B2C)
    • 6.2.4. By Application (Chronic Pain, Mental Disorders, Cancer, Epilepsy, Others)
    • 6.2.5. By End User Industry (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Others)
    • 6.2.6. By Region
    • 6.2.7. By Company (2022)
  • 6.3. Product Map
    • 6.3.1 By Product Type
    • 6.3.2 By Active Ingredient
    • 6.3.3 By Distribution Channel
    • 6.3.4 By Application
    • 6.3.5 By End User
    • 6.3.4 By Region

7. North America Medical Cannabis Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type (Buds/Marijuana Flower, Cannabis Extracts)
    • 7.2.2. By Active Ingredient (Tetrahydrocannabinol (THC), Cannabidiol (CBD), Others)
    • 7.2.3. By Distribution Channel (B2B, B2C)
    • 7.2.4. By Application (Chronic Pain, Mental Disorders, Cancer, Epilepsy, Others)
    • 7.2.5. By End User Industry (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Others)
    • 7.2.6. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Medical Cannabis Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Active Ingredient
        • 7.3.1.2.3. By Distribution Channel
        • 7.3.1.2.4. By Application
        • 7.3.1.2.5. By End User Industry
    • 7.3.2. Canada Medical Cannabis Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Active Ingredient
        • 7.3.2.2.3. By Distribution Channel
        • 7.3.2.2.4. By Application
        • 7.3.2.2.5. By End User Industry
    • 7.3.3. Mexico Medical Cannabis Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Active Ingredient
        • 7.3.3.2.3. By Distribution Channel
        • 7.3.3.2.4. By Application
        • 7.3.3.2.5. By End User Industry

8. Europe Medical Cannabis Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type (Buds/Marijuana Flower, Cannabis Extracts)
    • 8.2.2. By Active Ingredient (Tetrahydrocannabinol (THC), Cannabidiol (CBD), Others)
    • 8.2.3. By Distribution Channel (B2B, B2C)
    • 8.2.4. By Application (Chronic Pain, Mental Disorders, Cancer, Epilepsy, Others)
    • 8.2.5. By End User Industry (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Others)
    • 8.2.6. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. Germany Medical Cannabis Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Active Ingredient
        • 8.3.1.2.3. By Distribution Channel
        • 8.3.1.2.4. By Application
        • 8.3.1.2.5. By End User Industry
    • 8.3.2. Malta Medical Cannabis Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Active Ingredient
        • 8.3.2.2.3. By Distribution Channel
        • 8.3.2.2.4. By Application
        • 8.3.2.2.5. By End User Industry
    • 8.3.3. United Kingdom Medical Cannabis Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecasty
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Active Ingredient
        • 8.3.3.2.3. By Distribution Channel
        • 8.3.3.2.4. B y Application
        • 8.3.3.2.5. By End User Industry
    • 8.3.4. France Medical Cannabis Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By Active Ingredient
        • 8.3.4.2.3. By Distribution Channel
        • 8.3.4.2.4. By Application
        • 8.3.4.2.5. By End User Industry
    • 8.3.5. Denmark Medical Cannabis Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By Active Ingredient
        • 8.3.5.2.3. By Distribution Channel
        • 8.3.5.2.4. By Application
        • 8.3.5.2.5. By End User Industry
    • 8.3.6. Italy Medical Cannabis Market Outlook
      • 8.3.6.1. Market Size & Forecast
        • 8.3.6.1.1. By Value
      • 8.3.6.2. Market Share & Forecast
        • 8.3.6.2.1. By Product Type
        • 8.3.6.2.2. By Active Ingredient
        • 8.3.6.2.3. By Distribution Channel
        • 8.3.6.2.4. By Application
        • 8.3.6.2.5. By End User Industry
    • 8.3.7. Spain Medical Cannabis Market Outlook
      • 8.3.7.1. Market Size & Forecast
        • 8.3.7.1.1. By Value
      • 8.3.7.2. Market Share & Forecast
        • 8.3.7.2.1. By Product Type
        • 8.3.7.2.2. By Active Ingredient
        • 8.3.7.2.3. By Distribution Channel
        • 8.3.7.2.4. By Application
        • 8.3.7.2.5. By End User Industry

9. Asia-Pacific Medical Cannabis Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type (Buds/Marijuana Flower, Cannabis Extracts)
    • 9.2.2. By Active Ingredient (Tetrahydrocannabinol (THC), Cannabidiol (CBD), Others)
    • 9.2.3. By Distribution Channel (B2B, B2C)
    • 9.2.4. By Application (Chronic Pain, Mental Disorders, Cancer, Epilepsy, Others)
    • 9.2.5. By End User Industry (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Others)
    • 9.2.6. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. Australia Medical Cannabis Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Active Ingredient
        • 9.3.1.2.3. By Distribution Channel
        • 9.3.1.2.4. By Application
        • 9.3.1.2.5. By End User Industry
    • 9.3.2. China Medical Cannabis Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Active Ingredient
        • 9.3.2.2.3. By Distribution Channel
        • 9.3.2.2.4. By Application
        • 9.3.2.2.5. By End User Industry
    • 9.3.3. Thailand Medical Cannabis Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Active Ingredient
        • 9.3.3.2.3. By Distribution Channel
        • 9.3.3.2.4. By Application
        • 9.3.3.2.5. By End User Industry
    • 9.3.4. South Korea Medical Cannabis Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Product Type
        • 9.3.4.2.2. By Active Ingredient
        • 9.3.4.2.3. By Distribution Channel
        • 9.3.4.2.4. By Application
        • 9.3.4.2.5. By End User Industry
    • 9.3.5. India Medical Cannabis Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Product Type
        • 9.3.5.2.2. By Active Ingredient
        • 9.3.5.2.3. By Distribution Channel
        • 9.3.5.2.4. By Application
        • 9.3.5.2.5. By End User Industry

10. South America Medical Cannabis Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type (Buds/Marijuana Flower, Cannabis Extracts)
    • 10.2.2. By Active Ingredient (Tetrahydrocannabinol (THC), Cannabidiol (CBD), Others)
    • 10.2.3. By Distribution Channel (B2B, B2C)
    • 10.2.4. By Application (Chronic Pain, Mental Disorders, Cancer, Epilepsy, Others)
    • 10.2.5. By End User Industry (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Others)
    • 10.2.6. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Medical Cannabis Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Active Ingredient
        • 10.3.1.2.3. By Distribution Channel
        • 10.3.1.2.4. By Application
        • 10.3.1.2.5. By End User Industry
    • 10.3.2. Argentina Medical Cannabis Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Active Ingredient
        • 10.3.2.2.3. By Distribution Channel
        • 10.3.2.2.4. By Application
        • 10.3.2.2.5. By End User Industry
    • 10.3.3. Colombia Medical Cannabis Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Active Ingredient
        • 10.3.3.2.3. By Distribution Channel
        • 10.3.3.2.4. By Application
        • 10.3.3.2.5. By End User Industry

11. Middle East and Africa Medical Cannabis Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Product Type (Buds/Marijuana Flower, Cannabis Extracts)
    • 11.2.2. By Active Ingredient (Tetrahydrocannabinol (THC), Cannabidiol (CBD), Others)
    • 11.2.3. By Distribution Channel (B2B, B2C)
    • 11.2.4. By Application (Chronic Pain, Mental Disorders, Cancer, Epilepsy, Others)
    • 11.2.5. By End User Industry (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Others)
    • 11.2.6. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. Lebanon Medical Cannabis Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Product Type
        • 11.3.1.2.2. By Active Ingredient
        • 11.3.1.2.3. By Distribution Channel
        • 11.3.1.2.4. By Application
        • 11.3.1.2.5. By End User Industry
    • 11.3.2. South Africa Medical Cannabis Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Product Type
        • 11.3.2.2.2. By Active Ingredient
        • 11.3.2.2.3. By Distribution Channel
        • 11.3.2.2.4. By Application
        • 11.3.2.2.5. By End User Industry
    • 11.3.3. Israel Medical Cannabis Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Product Type
        • 11.3.3.2.2. By Active Ingredient
        • 11.3.3.2.3. By Distribution Channel
        • 11.3.3.2.4. By Application
        • 11.3.3.2.5. By End User Industry

12. Market Dynamics

  • 12.1. Drivers
    • 12.1.1 High prevalence of Chronic
    • 12.1.2 Legalization of Medical Cannabis
  • 12.2. Challenges
    • 12.2.1 High cost and not always readily available
    • 12.2.2 Less acceptance by the Consumer

13. Market Trends & Developments

  • 13.1. New Product Development
  • 13.2. Increasing use of Medical Cannabis by the medicinal and pharmaceutical industries.

14. Global Medical Cannabis Market: SWOT Analysis

15. Porter's Five Forces Analysis

  • 15.1. Competition in the Industry
  • 15.2. Potential of New Entrants
  • 15.3. Power of Suppliers
  • 15.4. Power of Customers
  • 15.5. Threat of Substitute Products

16. Competitive Landscape

  • 16.1. Business Overview
  • 16.2. Product Offerings
  • 16.3. Recent Developments
  • 16.4. Financials (As Reported)
  • 16.5. Key Personnel
  • 16.6. SWOT Analysis
      • 16.6.1.1. Canopy Growth Corporation
      • 16.6.1.2. Aphria, Inc.
      • 16.6.1.3. Maricann Group, Inc
      • 16.6.1.4. Tikun Olam - Cannabit Pharmaceuticals Ltd
      • 16.6.1.5. MedReleaf. Corp
      • 16.6.1.6. GW Pharmaceuticals plc.
      • 16.6.1.7. Cannabis Sativa, Inc.
      • 16.6.1.8. Medical Marijuana, Inc
      • 16.6.1.9. Aurora Marijuana Inc.
      • 16.6.1.10. Cronos Group Inc.

17. Strategic Recommendation